Not Yet RecruitingNot Applicable

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

United States254 participantsStarted 2026-05

Plain-language summary

The goal of this trial is to learn if a resilience intervention can lead to improvements in lymphoma survivors' quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * English or Spanish speaking adults (18+ at time of enrollment) * Within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy, immunotherapy, radiation therapy, or other) Exclusion Criteria: * Active psychiatric or cognitive comorbidity as determined by the site PI or treating clinician

What they're measuring

Quality of Life (QoL): Change in PROMIS-29

Timeframe: From enrollment to 6 month follow up

Trial details

NCT IDNCT07013435

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-01

View on ClinicalTrials.gov More Lymphoma trials